US Government Appeals Court Order Blocking Reductions to Childhood Vaccines
Washington, Friday, 1 May 2026.
The administration has appealed a ruling blocking Robert F. Kennedy Jr.’s childhood vaccine cuts, sparking a legal battle that could severely disrupt public health guidelines and pharmaceutical industry revenues.
Regulatory Uncertainty Following the Appeal
On Wednesday, April 29, 2026 [alert! ‘STAT News cites the Wednesday appeal filing as 2026-04-24, but AP News and calendar alignment indicate Wednesday, April 29, 2026’], the Department of Justice, representing the Trump administration, filed an appeal against a federal court order that had previously halted sweeping changes to the nation’s childhood vaccine schedule [1][2][3]. The original March 16 injunction, issued by U.S. District Judge Brian Murphy—a nominee of President Joe Biden—blocked Health Secretary Robert F. Kennedy Jr. from implementing policies that would significantly scale back immunization recommendations [1][2]. The government’s one-sentence filing, signed by Assistant Attorney General Brett Shumate, offered no specific reasoning for attempting to lift the block after a six-week delay [1][2].
The Legal Battle Over ACIP’s Reconstitution
The lawsuit challenging these cuts was spearheaded by the American Academy of Pediatrics (AAP) alongside other major medical organizations, arguing that the administration’s actions violated the Administrative Procedures Act [2][3]. The plaintiffs initially filed suit in July to contest Kennedy’s decision to halt COVID-19 vaccine recommendations for pregnant women and most children, but amended their complaint as the Health Secretary expanded his overhaul to the broader childhood schedule and the CDC’s Advisory Committee on Immunization Practices (ACIP) [1]. Judge Murphy’s March ruling determined that Kennedy had acted “unlawfully” when he fired the entire 17-member ACIP panel last year and replaced it with individuals holding anti-vaccine viewpoints [1][2].
Next Steps and Industry Implications
The trajectory of federal vaccine policy now rests on the appellate courts. The Justice Department has the option to file a motion for emergency relief, which would require the 1st U.S. Circuit Court of Appeals to act swiftly in deciding whether to stay Judge Murphy’s March 16 ruling [2]. Absent an emergency intervention, the legal proceedings are expected to unfold over several months of oral arguments [2]. Richard Hughes IV, the attorney representing the AAP, stated that his team expects to prevail against the government’s appeal, characterizing the administration’s efforts as the “steady destruction of vaccine policy and public health” [1][2][3]. Hughes has also indicated that the dispute could ultimately reach the Supreme Court [2].